Navigation Links
AstraZeneca's Rich Fante Elected as National Pharmaceutical Council's Chairman of the Board
Date:10/28/2011

WASHINGTON, Oct. 28, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Rich Fante, President, AstraZeneca U.S. and CEO North America, has been elected Chairman of its Board of Directors for 2011-12. Mr. Fante has served on NPC's Board since 2008, most recently as Treasurer.

"Rich takes the helm at a time when the health care landscape is continuing to change at a rapid pace. As someone with tremendous experience in the pharmaceutical industry, Rich understands how NPC's policy research can help inform decision-making among those shaping the future of health care delivery," said NPC President Dan Leonard.

"During my chairmanship, I'm looking forward to leading NPC as it positions itself for the future," said Mr. Fante. "NPC has an important and unique role to play in supporting the development and application of comparative effectiveness research and other data important to improving health outcomes.  By engaging with providers, payers, policymakers and other stakeholders, NPC will be able to meaningfully contribute to shaping the health care environment."

Prior to his current role at AstraZeneca, Mr. Fante served as the company's Vice President, Brand Strategy and Portfolio Operations.  He led the development and execution of marketing strategies for all AstraZeneca brands in the United States.  He has held a number of leadership roles at AstraZeneca, including Vice President—Primary Care for the gastrointestinal and respiratory franchises. Outside of AstraZeneca, Mr. Fante serves as a member of the Roundtable on Value & Science-Driven Health Care for the Institute of Medicine.

Mr. Leonard also recognized the efforts of the outgoing chair, Kevin T. Rigby, Vice President of Public Affairs and Communications at Novartis Pharmaceuticals Corporation, who will remain active on NPC's Board. "Under Kevin's leadership, we made great strides in increasing NPC's awareness and visibility with key CER stakeholders, as well as improving our infrastructure and business operations. We greatly appreciated his involvement in strengthening the organization," said Mr. Leonard.

The NPC Board also elected John Gargiulo, President and CEO of Daiichi Sankyo, Inc., to serve as its Vice Chairman, and Jeff Huth, Senior Vice President, Managed Markets, of Boehringer Ingelheim Pharmaceuticals, Inc., as Treasurer.  

About the National Pharmaceutical Council

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.  


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals
2. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
3. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
4. Christine Pierre Selected as "Professional Woman of the Year"
5. Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
6. Dr. Paul Farmer Selected as 2011 Pro Bono Humanum Honoree by Prix Galien USA
7. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
8. BioSurplus Selected to Auction $10 Million in Lab Equipment
9. Linet Multicare® Hospital Bed Selected to Participate in National Program Highlighting Commitment to Healthcare Performance Improvement, Innovation
10. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
11. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):